Financial Year |
March 31 2023 |
Monetary Funds |
401,809,599.38 |
Held-for-trading Financial Assets |
31,209,236.78 |
Notes Receivable |
22,644,508.95 |
Accounts Receivable |
1,233,169,711.38 |
Advances to Suppliers |
30,934,625.81 |
Other Receivables |
188,574,965.31 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
6,860,000.00 |
Inventories |
356,719,077.64 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
154,144,178.65 |
Total Current Assets |
2,443,801,566.80 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
49,614,332.80 |
Long-term Equity Investment |
423,180,981.52 |
Investment Properties |
58,404,756.61 |
Fixed Assetes |
2,917,684,608.68 |
Under-construction Projects |
593,899,711.95 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
183,381,225.43 |
R&D expenses |
-- |
Goodwill |
80,344,427.78 |
Long-Term Deferred and Prepaid Expenses |
118,492,678.89 |
Deferred Income Tax Assets |
92,997,704.12 |
Other Non-Current Assets |
98,703,431.09 |
Sub-Total of Non-Current Assets |
5,220,428,999.71 |
Total Assets |
7,664,230,566.51 |
Short-Term Loans |
310,684,881.27 |
Trading Financial liabilities |
-- |
Notes Payable |
137,798,878.78 |
Accounts Payable |
466,175,620.38 |
Accounts Received In Advance |
933,309.47 |
Employee Compensation Payable |
6,129,463.83 |
Taxes Payable |
21,740,096.17 |
Interest Payable |
-- |
Dividend Payable |
954,565.61 |
Other payables |
11,381,965.69 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
346,360,807.31 |
Other Current Liabilities |
2,280,536.52 |
Sub-Total of Current Liabilities |
1,378,073,611.27 |
Long-term Loans |
1,604,381,967.50 |
Bonds Payable |
255,751,050.99 |
Long-Term Accounts Payable |
850,269,263.87 |
Special Payable |
-- |
Estimatied Liabilities |
2,884,728.88 |
Deferred Income Tax Liabilities |
627,339.10 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
3,361,067,427.75 |
Total Liabilities |
4,739,141,039.02 |
Paid-In Capital(Or Share Stock) |
587,657,220.00 |
Capital Surplus |
1,043,896,776.89 |
Surplus Reserve |
102,899,285.28 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
1,056,725,543.73 |
Minority Stockholder's Interest |
53,570,076.36 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,871,519,451.13 |
Owner's Equity(Stockholder's Equity) |
2,925,089,527.49 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
7,664,230,566.51 |